My favorite new indie stock, Seelos Therapeutics, was recently upgraded from a price target of $4.70 to a whopping $15. For this to happen, it may have to beat some bears (in SPY) and sharks (in short interest). Short interest in the stock is down, with most shares not available to short. This is positive and bullish for shorter term. The stock market looks to...
TherapeuticsMD Inc (NASDAQ:TXMD) finally broke out of its downtrend line yesterday on decent volume. If this chart does what is supposed to do, it will be going higher in the days to come. Technically, the stock is in a short-term Bull Market with share price above 9 and 13daily EMA. Let's see if next week the stock will confirm the breakout. Let's keep an eye on...
shark harmonic pattern targets: AB=0.61 XA BC=1.6 AB tp1=0.88 XA=$25 tp2=1.13 XA=$38 tp3=1.6 BC=$82 tp4=2.24 BC=$340 other targets: tp5=0.78 BC=$12 tp6=0.88 BC=$15 tp7=0.78 XA=$$21 tp8=1.6 XA=1.6 BC=$82
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova’s novel, proprietary multi-kinase inhibitor ON 123300 is...
After a 4x gain in a day, my target for the possible retracement is usd5.4 Market Cap is still low, though: 64.341M Please leave me a message if you want to test the buy and sell indicators that i am using.
In February 2020, both Nexletol and Nexlizet were approved as oral treatments to lower LDL-C. Bempedoic acid remains in clinical trials of its efficacy in risk reduction for cardiovascular disease. Esperion shares peaked last February, after the FDA approvals, but since then, the stock has declined. Shares are down 65% since their peak. (tipranks.com) Analyst...
After showing some incredible strength in November, DNLI is cooling off forming a bullflag. Over 62.50 should capture the next leg up.
We love America, so when we heard yall needed some help with this Covid nonsense, my cuzins got on that. Relief Therapeutics Holdings AG, traded on the SIX, but also avaiable on OTC. I wont get to technical for all my american home boiz, but weve been injecting this stuff into our balls for years now, but we are more than happy to let yall use it to help youre...
Right now one of the stocks that have my attention, (partly because of Kevin O'Leary) and the rest of its history is Mind Medicine (MindMed Inc.) They are one of the first companies finding a way to neutralize LSD while working on a DMT based therapy drug. Also, the market cap and entry is low. This is one of those stocks where you need to dig deep into the pitch...
Unum Therapeutics (UMRX, $3.32) was one of top quarterly gainers, jumping +850.2% to $3.32 per share. Tickeron A.I.dvisor analyzed 382 stocks in the Biotechnology Industry over the last three months, and discovered that 327 of them (85.6%) charted an Uptrend while 55 of them (14.4%) trended down. Tickeron A.I.dvisor found 51 similar cases when UMRX's price went up...
REVIVE THERAPEUTICS has a Market Capitalization of only 27.158M, while the Net Income (FY) reveals a debt, -1.028M. Some analists predict an Average Target Price of 2.36 usd. The indicators are bullish on most timeframes. Still a lot of room to grow, with that huge volume. If you are interested to test some amazing buy and sell indicators, which give the signal...
Prices of Interest 🧐🤔: $1.96 $2.37 $2.62 Profit prices to consider 🧐🤔: $4.58
The trend if this current pattern is about to be decided... cross the red line sell! Cross the green line short profit! Share your Ideas in the comments below.
$SPRT is about to break the resistance of cup after a long consolidation. There are two options in front; one ise to break and to continue rising and the other one is forming a handle. If you find my charts useful, please just leave me a "Like" thx
Unconfirmed double bottom for $SRNE. It needs to break $2.66 for target price If you find my charts useful, please just "Like"
$TGTX is hitting the 5 years high. It did %65 in this week so far. RSI is still 66 on weekly and needs more for breakout. It may pull back before continues
Bold has seen some significant bullishness in the past weeks with a strong upward move, causing a golden cross, this is due to factors other than TA. (Beyond TA). This may be a 'bump' with a pullback occurring in the near future to the major trend.